Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital

Contributed by: PR Newswire

Tags

Codis-1315-capital-UK

More Like This

PR Newswire associated0

Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions

PR Newswire associated0

Codis Unlocks Commercial-Scale Amorphous Solid Dispersions Manufacturing with GEA PSD4 Solvent Spray Dryer Investment

PR Newswire associated0

Codis Appoints Steven Facer as Senior VP Sales and Marketing to Support the Haverhill, UK Facility

PR Newswire associated0

Cambrex Advances US and European Expansions

Merck invests €70 million to triple its antibody-drug conjugate (ADC) manufacturing capacity and upgrade 3200 m2 at its BioConjugation Center of Excellence in St. Louis, Missouri, USA. (Photo: Business Wire)

Merck Invests €70 Million to Expand ADC Manufacturing for Novel Cancer Therapies

LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood

LTS EXPANDS ITS CDMO CAPABILITIES WITH THE ACQUISITION OF RENAISSANCE LAKEWOOD

PR Newswire associated0

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan